Latest News

Experimental antibody shows early promise for treatment of childhood tumor

Tumors shrank or disappeared and disease progression was temporarily halted in 15 children with advanced neuroblastoma enrolled in a safety study of an experimental antibody. Four patients are still alive after more than two-and-a-half years and without additional treatment. Neuroblastoma is a cancer of the sympathetic nervous system. It is the most common cancer diagnosed in the first year of life and accounts for 7 to 10 percent of childhood cancers.
View full story

Post your comment.


  • Warning labels should be introduced to prevent digital addiction, research suggests

  • Study sheds light on protecting transgender individuals from suicide

  • People with higher 'intellectual arrogance' get better grades

  • Immune gene prevents Parkinson's disease, dementia

  • Dying at home leads to more peace, less grief, but requires wider support

  • Math story time at home bolsters achievement in school

  • Seeing in a new light

  • Smoking, heavy alcohol use are associated with epigenetic signs of aging

  • Opposites don't attract when learning how to use a prosthesis

  • Scientists build a digital piece of a rat's brain